555 related articles for article (PubMed ID: 20802148)
41. Fasudil exerts a cardio-protective effect on mice with coxsackievirus B3-induced acute viral myocarditis.
Dai K; Wang Y; Tai S; Ni H; Lian H; Yu Y; Liao W; Zheng C; Chen Q; Kuver A; Li J
Cardiovasc Ther; 2018 Dec; 36(6):e12477. PubMed ID: 30380183
[TBL] [Abstract][Full Text] [Related]
42. LncGBP9 knockdown alleviates myocardial inflammation and apoptosis in mice with acute viral myocarditis via suppressing NF-κB signaling pathway.
Xue Y; Zhang J; Ke J; Zeng L; Cheng K; Han X; Chen F; Chen F
Inflamm Res; 2022 Dec; 71(12):1559-1576. PubMed ID: 36301340
[TBL] [Abstract][Full Text] [Related]
43. Blocking the CD40-CD40L interaction by CD40-Ig reduces disease progress in murine myocarditis induced by CVB3.
Bo H; Zhenhu L; Lijian Z
Cardiovasc Pathol; 2010; 19(6):371-6. PubMed ID: 19914091
[TBL] [Abstract][Full Text] [Related]
44. Expression of immunoregulatory cytokines by recombinant coxsackievirus B3 variants confers protection against virus-caused myocarditis.
Henke A; Zell R; Ehrlich G; Stelzner A
J Virol; 2001 Sep; 75(17):8187-94. PubMed ID: 11483764
[TBL] [Abstract][Full Text] [Related]
45. T cells expressing the Vgamma1 T-cell receptor enhance virus-neutralizing antibody response during coxsackievirus B3 infection of BALB/c mice: differences in male and female mice.
Huber S; Sartini D
Viral Immunol; 2005; 18(4):730-9. PubMed ID: 16359239
[TBL] [Abstract][Full Text] [Related]
46. [Alteration of Th17 cells in mice with coxsackie virus induced myocarditis].
YANG F; LIN S; HUANG YL; WU WF
Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Sep; 38(9):790-3. PubMed ID: 21092645
[TBL] [Abstract][Full Text] [Related]
47. Coxsackievirus-induced myocarditis is dependent on distinct immunopathogenic responses in different strains of mice.
Huber SA
Lab Invest; 1997 May; 76(5):691-701. PubMed ID: 9166288
[TBL] [Abstract][Full Text] [Related]
48. Roles of programmed death-1 (PD-1)/PD-1 ligands pathway in the development of murine acute myocarditis caused by coxsackievirus B3.
Seko Y; Yagita H; Okumura K; Azuma M; Nagai R
Cardiovasc Res; 2007 Jul; 75(1):158-67. PubMed ID: 17434153
[TBL] [Abstract][Full Text] [Related]
49. Astragaloside IV exerts antiviral effects against coxsackievirus B3 by upregulating interferon-gamma.
Zhang Y; Zhu H; Huang C; Cui X; Gao Y; Huang Y; Gong W; Zhao Y; Guo S
J Cardiovasc Pharmacol; 2006 Feb; 47(2):190-5. PubMed ID: 16495755
[TBL] [Abstract][Full Text] [Related]
50. [The mechanisms responsible for the therapeutic effects of anti-Fas ligand antibody on viral myocarditis in mice].
Chang H; Han B; Han XZ
Zhonghua Er Ke Za Zhi; 2005 Dec; 43(12):920-4. PubMed ID: 16412356
[TBL] [Abstract][Full Text] [Related]
51. Tanshinone IIA Ameliorate Coxsackie Virus B3-Induced Viral Myocarditis through the Inhibition of Inflammation and Modulation T Helper 1/T Helper 2 Balance in Mice.
Guo G; Zhao Q; Wang Q; Li E
Pharmacology; 2019; 103(3-4):136-142. PubMed ID: 30602153
[TBL] [Abstract][Full Text] [Related]
52. TLR3 deficiency induces chronic inflammatory cardiomyopathy in resistant mice following coxsackievirus B3 infection: role for IL-4.
Abston ED; Coronado MJ; Bucek A; Onyimba JA; Brandt JE; Frisancho JA; Kim E; Bedja D; Sung YK; Radtke AJ; Gabrielson KL; Mitzner W; Fairweather D
Am J Physiol Regul Integr Comp Physiol; 2013 Feb; 304(4):R267-77. PubMed ID: 23255589
[TBL] [Abstract][Full Text] [Related]
53. Persistence of replicating coxsackievirus B3 in the athymic murine heart is associated with development of myocarditic lesions.
Sato S; Tsutsumi R; Burke A; Carlson G; Porro V; Seko Y; Okumura K; Kawana R; Virmani R
J Gen Virol; 1994 Nov; 75 ( Pt 11)():2911-24. PubMed ID: 7964602
[TBL] [Abstract][Full Text] [Related]
54. Interleukin-37 Ameliorates Coxsackievirus B3-induced Viral Myocarditis by Modulating the Th17/Regulatory T cell Immune Response.
An B; Liu X; Li G; Yuan H
J Cardiovasc Pharmacol; 2017 May; 69(5):305-313. PubMed ID: 28207428
[TBL] [Abstract][Full Text] [Related]
55. NOD2 (Nucleotide-Binding Oligomerization Domain 2) Is a Major Pathogenic Mediator of Coxsackievirus B3-Induced Myocarditis.
Tschöpe C; Müller I; Xia Y; Savvatis K; Pappritz K; Pinkert S; Lassner D; Heimesaat MM; Spillmann F; Miteva K; Bereswill S; Schultheiss HP; Fechner H; Pieske B; Kühl U; Van Linthout S
Circ Heart Fail; 2017 Sep; 10(9):. PubMed ID: 28912259
[TBL] [Abstract][Full Text] [Related]
56. Role of neutrophils in CVB3 infection and viral myocarditis.
Rivadeneyra L; Charó N; Kviatcovsky D; de la Barrera S; Gómez RM; Schattner M
J Mol Cell Cardiol; 2018 Dec; 125():149-161. PubMed ID: 30393107
[TBL] [Abstract][Full Text] [Related]
57. [Effect of IL-17A on levels of antiheart autoantibodies in mice with viral myocarditis].
Lai W; Wu W; Pan X; Kong Q
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jun; 30(6):601-3, 607. PubMed ID: 24909282
[TBL] [Abstract][Full Text] [Related]
58. Progranulin ameliorates coxsackievirus-B3-induced viral myocarditis by downregulating Th1 and Th17 cells.
Li L; Li L; Xiao L; Shangguan J
Exp Cell Res; 2018 Jun; 367(2):241-250. PubMed ID: 29625085
[TBL] [Abstract][Full Text] [Related]
59. The outcome of coxsackievirus B3-(CVB3-) induced myocarditis is influenced by the cellular immune status.
Leipner C; Grün K; Borchers M; Stelzner A
Herz; 2000 May; 25(3):245-8. PubMed ID: 10904846
[TBL] [Abstract][Full Text] [Related]
60. α-Galactosylceramide protects mice from lethal Coxsackievirus B3 infection and subsequent myocarditis.
Wu CY; Feng Y; Qian GC; Wu JH; Luo J; Wang Y; Chen GJ; Guo XK; Wang ZJ
Clin Exp Immunol; 2010 Oct; 162(1):178-87. PubMed ID: 20726989
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
